India has ordered its pharmaceutical companies to meet new manufacturing standards this year after a string of deaths reported overseas linked to Indian-made drugs since 2022.
Following deaths linked to India-made cough syrups in countries including Gambia and Uzbekistan, prime minister Narendra Modi’s government increased scrutiny of drug-making factories to restore trust in the country’s image as the “pharmacy of the world”.
…
In 2022, more than 60 children, most under five years of age, died as a result of acute kidney injuries which were linked to cough syrups made in India.
In the same year, 19 children in Uzbekistan who consumed cough syrups made in India died.
Then last year, the manufacturer of over two dozen varieties of eyedrops was subject to a US safety warning officially recalling the products.
The US’s FDA had warned consumers not to use the products due to the risk of vision loss or blindness.
The WHO also flagged a batch of a “contaminated” cough syrup made in India and found in the Marhsall Islands and Micronesia in 2023.
You think Indians would be furious with Modi for not doing this to improve the safety of his own citizens using the medicine.
Its sadly funny when a ethnonationalist cares more about the lives of foreigners than the people he’s meant to represent.
What reputation?
As the worlds largest and cheapest pharmaceutical system?
It’s like the only one good thing India has going for it. Well their space program is okay as well.
I out India quality below China and I once had an argument with a Chinese manufacturer about the soec requiring Stainless 304 and he used iron and stated his iron is the best iron in China and never rusts.
This is the best summary I could come up with:
India has ordered its pharmaceutical companies to meet new manufacturing standards this year after a string of deaths reported overseas linked to Indian-made drugs since 2022.
In 2022, more than 60 children, most under five years of age, died as a result of acute kidney injuries which were linked to cough syrups made in India.
Then last year, the manufacturer of over two dozen varieties of eyedrops was subject to a US safety warning officially recalling the products.
The Indian health ministry’s inspections of 162 drug factories since December 2022 found an “absence of testing of incoming raw materials”.
To ensure safety of pharma products made in the country, India has ordered its drug-makers to follow new standards.
Drug manufacturers must also retain a sufficient quantity of the samples of intermediate and final products to allow repeated testing or verification of a batch, the Indian government said.
The original article contains 401 words, the summary contains 147 words. Saved 63%. I’m a bot and I’m open source!
